Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
J Ethnopharmacol. 2020 Jul 15;257:112910. doi: 10.1016/j.jep.2020.112910. Epub 2020 Apr 25.
Artemisia aucheri Bioss contains flavonoid, coumarin and santonin with antioxidant, antimicrobial and antileishmanial effects. The current study was aimed to comparatively evaluate the effects of spring and autumn extracts of A. aucheri Bioss on Leishmania major both in-vitro and in-vivo conditions.
HPLC analysis was used to evaluate the percentages of compounds in spring and autumn extracts of A. aucheri. For in-vitro assay, the effect of different concentrations of spring and autumn extracts of A. aucheri was tested on L. major promastigotes and amastigotes. MTT and flow cytometry methods were used to evaluate the cytotoxicity and probable apoptosis of A. aucheri extracts on L. major promastigotes. On the other hand, for in-vivo assay, the extracts were used as ointments to treat lesions developed on BALB/c mice after 28 days post inoculation of L. major. The diameter of lesions and the survival rates of infected BALB/c mice were measured weekly for a period of two months.
The HPLC analysis showed the substance Quercitrin was present in the spring A. aucheri extract but not in the autumn extract. The mean numbers of amastigotes in each treated macrophage with the spring and autumn A. aucheri extracts were 1.2 and 1.8 respectively, which showed statistically significant differences (P < 0.05). Flow cytometry revealed that the spring and autumn A. aucheri extracts caused about 32% and 3.78% apoptosis respectively. The inhibitory concentration (IC50) of spring and autumn A. aucheri extracts to amastigotes were determined to be 90 μg/mL and 183 μg/mL respectiovely. In-vivo, the diameter of lesions treated with the spring A. aucheri extract was significantly less (P < 0.05) compared to those treated with the autumn extract (2.6 and 7.8 mm respectively). Also, mice treated with spring A. aucheri extract had higher survival rates compared to control group.
Given the above results, it can be concluded that spring A. aucheri extract has a greater fatality effect on L. major promastigotes in-vitro compared to the autum extract. In addition, the spring extract has stronger therapeutic effect on lesions caused by L. major in BALB/c mice than the autum extract.
艾草含有黄酮类、香豆素和蛔蒿素,具有抗氧化、抗菌和抗利什曼原虫作用。本研究旨在比较评估艾草春、秋提取物对体外和体内利什曼原虫的影响。
采用高效液相色谱法分析艾草春、秋提取物中化合物的百分含量。体外试验中,不同浓度的艾草春、秋提取物作用于利什曼原虫前鞭毛体和无鞭毛体。MTT 和流式细胞术检测艾草提取物对利什曼原虫前鞭毛体的细胞毒性和可能的细胞凋亡作用。另一方面,体内试验中,将提取物制成软膏,用于 BALB/c 小鼠接种利什曼原虫 28 天后的病变治疗。每周测量病变直径和感染 BALB/c 小鼠的存活率,持续两个月。
HPLC 分析表明,槲皮素在艾草春提取物中存在,但在秋提取物中不存在。用艾草春、秋提取物处理的每个巨噬细胞中的无鞭毛体数量分别为 1.2 和 1.8,差异有统计学意义(P<0.05)。流式细胞术显示,艾草春、秋提取物分别引起约 32%和 3.78%的细胞凋亡。艾草春、秋提取物对无鞭毛体的半数抑制浓度(IC50)分别为 90μg/mL 和 183μg/mL。体内试验中,艾草春提取物治疗的病变直径明显小于秋提取物(分别为 2.6 和 7.8mm)(P<0.05)。此外,艾草春提取物治疗组的小鼠存活率高于对照组。
鉴于上述结果,可以得出结论,艾草春提取物对体外利什曼原虫前鞭毛体的致死作用大于秋提取物。此外,艾草春提取物对 BALB/c 小鼠利什曼原虫引起的病变的治疗效果强于秋提取物。